Shukra Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 505931,
    "name": "Shukra Pharma.",
    "stock_name": "Shukra Pharma.",
    "full_name": "Shukra Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/shukra-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "34.75",
    "chg": 0.86,
    "chgp": "2.54%",
    "dir": 1,
    "prev_price": "33.89",
    "mcapval": "1,521.63 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524632,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE551C01044",
    "curr_date": "Jul 14, 02:55 PM",
    "curr_time": "14:56 PM",
    "last_traded_at": "Jul 14, 02:55 PM IST",
    "bse_nse_vol": "2.26 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 14, 2026",
    "traded_date_str": "2026 07 14",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Shukra Pharmaceuticals Ltd Faces Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-faces-mixed-technical-signals-amid-price-momentum-shift-4099876",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShukraPharmaceu_technicaldot_4099876.png",
        "date": "2026-07-14 08:02:25",
        "description": "Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum from sideways to mildly bearish. Despite some bullish signals on weekly indicators, monthly trends and moving averages suggest caution for investors as the stock price declined by 1.63% on 14 Jul 2026, closing at ₹33.89."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-sell-4094930",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShukraPharmaceu_mojoScore_4094930.png",
        "date": "2026-07-09 10:11:23",
        "description": "Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 July 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4092788",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShukraPharmaceu_technicaldot_4092788.png",
        "date": "2026-07-08 08:02:38",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a transition from a mildly bearish trend to a sideways movement. Despite a strong intraday gain of 4.78%, the stock’s technical landscape remains nuanced, with weekly and monthly signals diverging across key metrics such as MACD, RSI, Bollinger Bands, and moving averages."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4089924",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShukraPharmaceu_technicaldot_4089924.png",
        "date": "2026-07-06 08:01:41",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a 7.57% gain on 6 July 2026, signalling a potential change in market sentiment. Despite this short-term strength, technical indicators present a nuanced picture, with several metrics suggesting a cautiously bearish outlook amid mixed signals from key oscillators and moving averages."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-sell-4075951",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShukraPharmaceu_mojoScore_4075951.png",
        "date": "2026-06-28 10:10:06",
        "description": "Shukra Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-sell-4058921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShukraPharmaceu_mojoScore_4058921.png",
        "date": "2026-06-17 10:10:03",
        "description": "Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 17 June 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-faces-bearish-momentum-amid-technical-downgrade-4043261",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShukraPharmaceu_technicaldot_4043261.png",
        "date": "2026-06-10 08:02:49",
        "description": "Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 30 April 2026. The stock’s recent price action and technical indicators suggest increasing bearish pressure, with the share price retreating 3.42% on 10 June 2026 to close at ₹30.78, down from the previous close of ₹31.87."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4040011",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShukraPharmaceu_technicaldot_4040011.png",
        "date": "2026-06-09 08:00:45",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a modest daily price increase of 1.30%, the stock’s technical indicators reveal a nuanced momentum change, prompting a downgrade in its Mojo Grade from Hold to Sell as of 30 April 2026."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-sell-4037679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShukraPharmaceu_mojoScore_4037679.png",
        "date": "2026-06-06 10:10:19",
        "description": "Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 648,
    "sid": "505931",
    "stock_news_url": "https://www.marketsmojo.com/news/shukra-pharmaceuticals-505931"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
      "datetime": "06-Jul-2026",
      "details": "EGM",
      "source": "BSE"
    },
    {
      "caption": "EGM Voting Results",
      "datetime": "06-Jul-2026",
      "details": "EGM Voting Results",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jul-2026",
      "details": "Reg 74(5)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25",
          "dt": "2025-03-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24",
          "dt": "2024-04-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23",
          "dt": "2023-02-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Shukra Pharmaceuticals Ltd Faces Mixed Technical Signals Amid Price Momentum Shift

2026-07-14 08:02:25

Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum from sideways to mildly bearish. Despite some bullish signals on weekly indicators, monthly trends and moving averages suggest caution for investors as the stock price declined by 1.63% on 14 Jul 2026, closing at ₹33.89.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Sell

2026-07-09 10:11:23

Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 July 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-08 08:02:38

Shukra Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a transition from a mildly bearish trend to a sideways movement. Despite a strong intraday gain of 4.78%, the stock’s technical landscape remains nuanced, with weekly and monthly signals diverging across key metrics such as MACD, RSI, Bollinger Bands, and moving averages.

Read full news article

Shukra Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-07-06 08:01:41

Shukra Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a 7.57% gain on 6 July 2026, signalling a potential change in market sentiment. Despite this short-term strength, technical indicators present a nuanced picture, with several metrics suggesting a cautiously bearish outlook amid mixed signals from key oscillators and moving averages.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Sell

2026-06-28 10:10:06

Shukra Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Sell

2026-06-17 10:10:03

Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 17 June 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Shukra Pharmaceuticals Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-06-10 08:02:49

Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 30 April 2026. The stock’s recent price action and technical indicators suggest increasing bearish pressure, with the share price retreating 3.42% on 10 June 2026 to close at ₹30.78, down from the previous close of ₹31.87.

Read full news article

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-09 08:00:45

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a modest daily price increase of 1.30%, the stock’s technical indicators reveal a nuanced momentum change, prompting a downgrade in its Mojo Grade from Hold to Sell as of 30 April 2026.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Sell

2026-06-06 10:10:19

Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News